Advanced searches left 3/3

Cell Carcinoma - Springer Nature

Summarized by Plex Scholar
Last Updated: 10 January 2023

* If you want to update the article please login/register

Thermosensitive and mucoadhesive hydrogel containing curcumin-loaded lipid-core nanocapsules coated with chitosan for the treatment of oral squamous cell carcinoma

A buccal drug administration may be selected as a therapeutic approach to treat various disorders for local or systemic effects. Hydroxypropylmethylcellulose and Poloxamer 407 were used for hydrogel manufacturing. For LNCc and 179 nm for CLNCc, he obtained uniform homogeneous particles with average diameter, 173 nm for LNCc and 173 nm for CLNCc. A PDI equals to 0. 09 u00b1 0. 02 for LNCc and 0. 26 u00b1 0. 01 for CLNCc, indicating homogeneity. In comparison to the nanocapsules in suspension, increased mucoadhesion for hydrogels was present on the mucous membrane longer than the former, which washed on the membrane for 90 min only. Formulations were tested for their efficacy in an in vitro study of oral squamous cancer cell line, resulting in a dramatic decline in cell viability on both test groups.

Source link: https://doi.org/10.1007/s13346-022-01227-1


Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

The primary cause of locoregionally advanced unresectable squamous cell carcinoma was radical chemoradiotherapy, according to the authors. Methods We examined the long-term, clinical results, and safety data of induction chemotherapy using docetaxel-cisplatin-5FU and subsequent surgical or radical chemoradiotherapy in locally advanced unresectable esophageal cancer in Queen Mary Hospital, Hong Kong, which was published in King Mary Hospital, Hong Kong, which is located in Hong Kong. Induction DCF was given to a total of 47 patients with locoregionally advanced unresectable esophageal cancer. 24 patients underwent radical surgery and seven others had definitive CRT after being induction DCF. Conclusions The median overall survival was much longer in patients who underwent surgery than those with definitive CRT and no definitive therapy. Patients who underwent surgery, female, and those with supraclavicular lymph node involvement had a better OS. Eleven patients who had surgery had postoperative problems, and none of them had postoperative mortality.

Source link: https://doi.org/10.1245/s10434-022-12694-8


Sex Differences in Renal Cell Carcinoma: The Importance of Body Composition

Methods This retrospective review included 470 patients with RCC who underwent nephrectomy between 2006 and 2019. At the level of L3, abdominal fat measurements and psoas muscle area were determined. Women had a higher subcutaneous and male fat area, a greater proportion of visceral fat area, and a poorer psoas muscle index. men: OR 0. 97 percent CI, 0. 012]; women: 0. 9 percent CI, 0. 95 percent CI, 0. 012]). According to a randomized regression study, a correlation between increased psoas muscle index and lower grade tumors was found in conjunction with increased psoas index and lower grade tumors [women: odds ratio 0. 94, 0. 9, 9. 96 percent confidence interval 0. 95]; men: 0. 1, 0. 05, 0. 9, 0. 05, 0. 011, 0. 012] 0. 012], 0. 05, 0. 05, 0. 05, 0. 05, 0. 95, 0. 011, 0. 05, 0. 99, 0. 05, 0. 012] 0. 99, 0. 9, 0. 99, 0. 95, 0. 99, 0. 95, a 0. 99, u20130. 99, 0. 05, 1. 01, 1. 01u20130. 99, 0. 05, 1. 25 confidence interval 0. 95, 0. 99, 0. 99, 0. 99, 0. 99, 0. 99, u20130. 99, p = 0. 6 Psoas muscle index correlated with overall survival women in the OR 1. 41, 93% CI 1. 63, p = 0. 033; women: OR 1. 62; men: OR 1. 62 p. Conclusions: A higher preoperative psoas muscle index was independently linked to overall RCC survival, with a greater presence in males than in females, with a larger association in men than in women.

Source link: https://doi.org/10.1245/s10434-022-12738-z


Treatment and Outcomes of Proximal Esophageal Squamous Cell Carcinoma

This review reviewed the treatment of proximal esophageal squamous cell carcinoma, for which chemotherapy is the indicated therapy. Methods The National Cancer Database's treatment and outcomes of patients with cT1-3N0-1M0 proximal esophageal SCC in the National Cancer Database between 2004 and 2016 were evaluated using logistic regression, Kaplanu2013Meier analysis, and propensity-score matching. Patients treated with definitive therapy were significantly more successful in patients treated with definitive therapy than patients not treated definitively. In multivariable survival studies, definitive therapy was associated with improved survival, while increasing age, male sex, clinical T3 stage, positive medical nodal involvement, and the rise of the Charlson Comorbidity Index were all associated with decreased survival. In multivariable analysis of the definitive therapy cohort or propensity matched analysis, Esophagectomy was not associated with improved survival. However, the pathologic complete response for patients who underwent chemoradiation was only 33 percent for patients.

Source link: https://doi.org/10.1245/s10434-022-12683-x


Transient loss of consciousness immediately after total pancreatectomy for pancreatic metastases from renal cell carcinoma: a case report

Background The pancreatic disease treatment of various pancreatic disorders is often combined with total pancreatectomy. Case study A 77-year-old man who had undergone right nephrectomy for renal cell carcinoma 11 years ago appeared with multiple histologically diagnosed pancreatic metastases. The glucose level and pH gradually increased after the introduction of continuous intravenous insulin infusion and the discontinuation of fentanyl. Conclusion This case illustrates the importance of active monitoring of the glycemic state and pH after TP, as well as the lingering effects of anesthesia.

Source link: https://doi.org/10.1186/s40792-022-01583-7


Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma

Squamous cell carcinoma of the esophagus is a fatal disease of the esophagus with poor prognosis and a high incidence of lymphatic metastases. Methods For this study, we used biopsy from the Imam Khomeini Cancer Institute's tumor bank in Tehran, Iran, to collect 40 ESCC tumor samples and their normal margin counterparts. Bioinformatics analysis was carried out by the Graphpad prism version 8 for bioinformatics analysis. PVT1, CCAT1, and c-MYC were all found to be significant upregulation of ESCC tissues in comparison to non-tumor tissues, according to a c-MYC study. Patients with increased PVT1 expression had higher rates of advanced stage and lymph node metastasis, even though increased CCAT1 expression was only related to advanced stage and wasn't associated with lymph node metastasis, according to a study by the University of On the other hand, patients with ESCC who had risen PVT1 expression also had higher rates of advanced stage and lymph node metastasis, although increasing CCAT1 expression was only related to advanced stage and lymph node metastasis Conclusion In ESCC, this is the first study that shows that CCAT1, PVT1, and c-MYC can be up-regulated simultaneously.

Source link: https://doi.org/10.1186/s12885-022-10464-z


Cost-Effectiveness Analysis of Toripalimab Plus Paclitaxel and Cisplatin as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Introduction Toppingalimab plus paclitaxel and cisplatin treatment in China is extremely effective for patients with advanced or metastatic esophageal squamous cell carcinoma, although the consequences on economic growth are uncertain. The present research sought to determine the cost-effectiveness of TTP from the perspective of the Chinese healthcare system. Methods A Markov model was created to determine the cost-effectiveness of TTP therapy for patients with advanced or metastatic ESCC. Conclusions The total cost of TTP was $ 123,646. 63 and gained 1. 10 QALYs, according to the paclitaxel and cisplatin chemotherapy group, which yielded 0. 84 QALY at a cost of $ 16,259. 65. With an additional 0. 26 QALY, first-line TTP treatment yielded an incremental cost of $ 7,386. 78 per year, bringing an ICER of $ 28,348. 42/QALY, which was lower than the WTP threshold in China. Conclusions TTP was more cost-effective than TP chemotherapy from the Chinese healthcare perspective, with the Chinese healthcare system being unified.

Source link: https://doi.org/10.1007/s12325-022-02402-z


Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making

Objectivity: To develop a risk stratification model based on the International Federation of Gynecology and Obstetrics staging, as well as a squamous cell carcinoma antigen for the classification of patients with cervical squamous cell carcinoma into various risk groups, please see the link below. Methods We retrospectively reviewed 664 women with stage IIA CSCC's 2016 FIGO staging system, which received definitive radiotherapy from March 2013 to December 2017 at Sun Yat-Sen University Cancer Center's department of radiation oncology. Using receiver operating characteristic curve estimation, cutoff values for continuous variables were estimated for continuous variables.

Source link: https://doi.org/10.1007/s00432-022-04558-1


Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer Centre

Background Merkel cell carcinoma is a rare but highly infectious neuroendocrine skin disease, with Australia having the world's highest incidence. Methods This was a retrospective review of existing medical records of MCC patients presenting to the Peter MacCallum Cancer Centre between 1980 and 2018. According to the estimates, 5-year OS and DFS were 46% and 34 percent respectively. On multivariable analyses, older age at diagnosis, higher primary tumour diameter, and older primary tumor diameter were all associated with reduced OS. In patients treated with post-operative radiotherapy, positive or negative histopathological margin status was not related to OS or DFS differences. Conclusions: About a third of patients' locoregional recurrence, distal recurrence, or both, according to our study, and there hasn't been any change in the last four decades. There is no difference in OS or DFS with positive surgical margins when treated with adjuvant radiotherapy.

Source link: https://doi.org/10.1186/s12885-022-10349-1

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions